+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Prostate Cancer Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026

  • ID: 5147316
  • Report
  • September 2020
  • Region: Global
  • 150 pages
  • OG Analysis

FEATURED COMPANIES

  • 3D Signatures
  • Abbott
  • Beckman Coulter
  • Biomérieux Sa
  • Diasorin S.P.A
  • GEnomic Health
The study predicts the short term and long term trends that can shape the future of the Prostate Cancer Diagnostics market including the COVID-19 pandemic implications for the Prostate Cancer Diagnostics industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Prostate Cancer Diagnostics market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Prostate Cancer Diagnostics Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Prostate Cancer Diagnostics market forecast and Prostate Cancer Diagnostics market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020-2026 as the forecast period. The research was based on the findings of an expert team of analysts analyzing the Prostate Cancer Diagnostics market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Prostate Cancer Diagnostics industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening the Prostate Cancer Diagnostics market share in developed countries.

Scope of the Research

Global Prostate Cancer Diagnostics Market is analyzed and forecast over the outlook period from 2020 to 2026 by type including
Preliminary Tests
Confirmatory Tests
PCA3Test
Trans-rectal ultrasound
Biopsy
Others

Top Companies Operating in the Prostate Cancer Diagnostics market include 3D Signatures, Abbott, Beckman Coulter, bioMérieux SA, DiaSorin S.p.A, Genomic Health, MDxHealth, Myriad Genetic, OPKO Health, Roche
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3D Signatures
  • Abbott
  • Beckman Coulter
  • Biomérieux Sa
  • Diasorin S.P.A
  • GEnomic Health
1. Table of Contents
1.1 List of Tables
1.2 List of Figures

2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Prostate Cancer Diagnostics Market- Key Findings, 2020

3. Strategic Imperatives on Global Prostate Cancer Diagnostics Market
3.1 Covid-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End-user Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Prostate Cancer Diagnostics Companies

4. Global Prostate Cancer Diagnostics Market Value Outlook to 2026 Outlook by Type
4.1 Preliminary Tests
4.2 Confirmatory Tests
4.2.1 Pca3Test
4.2.2 Trans-Rectal Ultrasound
4.2.3 Biopsy
4.3 Others

5 Asia-Pacific Prostate Cancer Diagnostics Market Value Outlook to 2026
5.1 Leading Prostate Cancer Diagnostics Types Contributing to Asia-Pacific Market
5.2 Top Applications Contributing to Asia-Pacific Prostate Cancer Diagnostics
5.3 Top Countries Contributing to Asia-Pacific Prostate Cancer Diagnostics

6 Europe Prostate Cancer Diagnostics Market Value Outlook to 2026
6.1 Leading Prostate Cancer Diagnostics Types Contributing to Europe Market
6.2 Top Applications Contributing to Europe Prostate Cancer Diagnostics
6.3 Top Countries Contributing to Europe Prostate Cancer Diagnostics

7 North America Prostate Cancer Diagnostics Market Value Outlook to 2026
7.1 Leading Prostate Cancer Diagnostics Types Contributing to North America Market
7.2 Top Applications Contributing to North America Prostate Cancer Diagnostics
7.3 Top Countries Contributing to North America Prostate Cancer Diagnostics

8 South and Central America Prostate Cancer Diagnostics Market Value Outlook to 2026
8.1 Leading Prostate Cancer Diagnostics Types Contributing to South and Central America Market
8.2 Top Applications Contributing to South and Central America Prostate Cancer Diagnostics
8.3 Top Countries Contributing to South and Central America Prostate Cancer Diagnostics

9 Middle East Africa Prostate Cancer Diagnostics Market Value Outlook to 2026
9.1 Leading Prostate Cancer Diagnostics Types Contributing to Middle East Africa Market
9.2 Top Applications Contributing to Middle East Africa Prostate Cancer Diagnostics
9.3 Top Countries Contributing to Middle East Africa Prostate Cancer Diagnostics

10 Business Profiles of Leading Companies
10.1 Business Description, SWOT and Financial Analysis of Companies in Prostate Cancer Diagnostics Market
10.2 3D Signatures
10.3 Abbott
10.4 Beckman Coulter
10.5 Biomérieux Sa
10.6 Diasorin S.P.A
10.7 Genomic Health
10.8 Mdxhealth
10.9 Myriad Genetic
10.10 Opko Health
10.11 Roche

11 Recent Industry Developments

12 Appendix
12.1 Analyst Expertise
12.2 Sources and Methodology
12.3 Contacts
Note: Product cover images may vary from those shown
  • 3D Signatures
  • Abbott
  • Beckman Coulter
  • Biomérieux Sa
  • Diasorin S.P.A
  • GEnomic Health
  • Mdxhealth
  • Myriad GEnetic
  • Opko Health
  • Roche
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll